Skip to main content
. 2022 Jun 14;39(8):3472–3487. doi: 10.1007/s12325-022-02169-3

Fig. 2.

Fig. 2

Possible mechanisms underlying the cardioprotective effects of SGLT2is on HF [3149]. Figure created with icons made by Freepik from www.flaticon.com. ATP adenosine triphosphate, HF heart failure, SGLT2is sodium–glucose cotransporter 2 inhibitors